PRINCETON, NJ–(Marketwired – Sep 23, 2013) – PeriGen today announced that its real-time perinatal clinical decision support (CDS) surveillance capabilities were underscored by KLAS Enterprises, LLC as demonstrating the most progress among companies that develop software applications specific to the hospital Labor & Delivery (L&D) department.
The KLAS report released Aug. 6th titled “CDS Surveillance 2013: Impacting Outcomes” states: “When asked about CDS surveillance capabilities, most L&D providers showed little progress, excepting PeriGen.”
PeriGen software user comments include:
- “The actionable alerts in PeriGen can be an annoyance to a seasoned physician, but at the same time, they can be incredibly valuable. Because of the alerts, we have caught some important things in a timely way.”
- “PeriGen provides a rule book that says if A happens, then B, C, and D will be the plan. If we need to tweak anything in the rule book, we can do that. It is very helpful.”
The PeriGen’s PeriCALM® Plus™ complete perinatal charting and fetal monitoring system includes PeriCALM® Tracings™, PeriCALM Patterns™ and PeriCALM Curve™. PeriCALM Patterns is the only fetal strip interpretation technology that is validated by the National Institutes of Health (NIH). Together, these solutions support and empower obstetrics clinicians in delivering optimal care of mothers and their babies at the bedside.
PeriGen solutions also interface seamlessly with a variety of market leading enterprise-wide electronic health record (EHR) systems including Computer Programs and Systems, Inc., MEDITECH, Allscripts’ Sunrise, GE Healthcare’s Centricity Enterprise, Epic and the Epic Stork, the OB/GYN module for Epic.
“Hospitals and health systems recognize the superiority of our evidence-based fetal monitoring and surveillance technology and ease of interfacing with leading EHR enterprise systems,” said Matthew Sappern, PeriGen’s CEO. “The KLAS study validates that providers today are looking for companies like PeriGen, the market’s gold standard in delivering decision support perinatal solutions, to improve their OB patient care and safety, and to help ensure sustainability with long-term EHR deployment plans.”
KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS’ mission is to improve delivery of healthcare, by independently measuring vendor performance for the benefit of healthcare provider partners, consultants, investors, and vendors by collecting accurate, honest and impartial provider experiences. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
About PeriGen, Inc.
PeriGen, Inc., is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. PeriGen’s customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.
PeriGen’s unique fetal surveillance products provide dynamic visual cues that direct clinicians to the most essential patient information displayed on the screen. Unlike legacy fetal monitoring devices and software from non-specialist companies, PeriGen Visual Cueing™ provides an instant view of the mother’s and baby’s current status and trends over time to avoid errors, increasing patient safety and reducing risk for clinicians and hospitals. For more information, please visit us at www.PeriGen.com.